Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials

MM Elmassry, JA Colmer-Hamood, J Kopel… - Microorganisms, 2023 - mdpi.com
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes high
morbidity and mortality in cystic fibrosis (CF) and immunocompromised patients, including …

[HTML][HTML] Potential anti-inflammatory effect of erythropoietin in non-clinical studies in vivo: A systematic review

I Silva, C Alípio, R Pinto, V Mateus - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Erythropoietin (EPO) is a hypoxia-induced hormone produced in adult kidneys with
erythropoietic and non-erythropoietic effects. In vivo studies represent an important role to …

Repurposing of high-dose erythropoietin as a potential drug attenuates sepsis in preconditioning renal injury

W Chancharoenthana, K Udompronpitak… - Cells, 2021 - mdpi.com
Due to (i) the uremia-enhanced sepsis severity,(ii) the high prevalence of sepsis with pre-
existing renal injury and (iii) the non-erythropoiesis immunomodulation of erythropoietin …

IgM-enriched immunoglobulins (Pentaglobin) may improve the microcirculation in sepsis: a pilot randomized trial

R Domizi, E Adrario, E Damiani, C Scorcella… - Annals of Intensive …, 2019 - Springer
Abstract Background Polyclonal or IgM-enriched immunoglobulins may be beneficial during
sepsis as an adjuvant immunomodulatory therapy. We aimed to test whether the infusion of …

[HTML][HTML] Erythropoietin-mediated IL-17 F attenuates sepsis-induced gut microbiota dysbiosis and barrier dysfunction

H Ling, Y Lin, W Bao, N Xu, L Chen, L Zhao… - Biomedicine & …, 2023 - Elsevier
Septic gut damage is critical in the progression of sepsis and multiple organ failure,
characterized by gut microbiota dysbiosis and epithelium deficiency in the gut barrier …

[HTML][HTML] Sepsis: immunopathology, immunotherapies, and future perspectives

T Tavaci, N Akgun - The Eurasian Journal of Medicine, 2022 - ncbi.nlm.nih.gov
Sepsis is a syndrome that includes physiological, pathological, and biochemical
abnormalities resulting from the host immune response to infection. Despite the improved …

PTX3 protects intestinal mucosal barrier damage in sepsis through toll-like receptor signaling pathway

J Li, Y Li, R Chai, X Yu, Z Yu - Inflammation, 2022 - Springer
This study aims to confirm the protective effect of Pentraxin 3 (PTX3) on intestinal mucosal
barrier damage in sepsis in animal and cell models and explore its mechanism. Analysis of …

Multifaceted Tissue-Protective Functions of Polyvalent Immunoglobulin Preparations in Severe Infections—Interactions with Neutrophils, Complement, and …

C Schmidt, S Weißmüller, CC Heinz - Biomedicines, 2023 - mdpi.com
Severe infections induce immune defense mechanisms and initial tissue damage, which
produce an inflammatory neutrophil response. Upon dysregulation of these responses …

Restoration of the Mucosal IgA Response by Improving CD4+ T Pyroptosis Fails to Attenuate Gut Bacterial Translocation and Organ Damage After LPS Attack

ZM Liu, Y Zhang, H Zhang, X Chen, H Peng… - Digestive Diseases and …, 2024 - Springer
Background Currently, the mechanisms of impaired gut mucosal immunity in sepsis remain
unclear. Gut immunoglobulin A (IgA) is an important defense mechanism against invasive …

Characteristics of immunoglobulin M type antibodies of different origins from the immunologic and clinical viewpoints and their application in controlling antibody …

Y Matsuda, T Hiramitsu, X Li, T Watanabe - Pathogens, 2020 - mdpi.com
Antibody-mediated allograft rejection (AMR) hinders patient prognosis after organ
transplantation. Current studies concerning AMR have mainly focused on the diagnostic …